Arcturus Therapeutics Ltd.
CIK 0001566049
Revenue (TTM)
—
Q1 May 2019
Net Income (TTM)
−$27.66M
−99.8% YoY
Q1 May 2019
EPS Diluted (TTM)
—
Q1 May 2019
Gross Margin
—
Q1 May 2019
Operating Margin
—
Q1 May 2019
Net Margin
—
Q1 May 2019
Free Cash Flow (TTM)
−$22.24M
Q1 May 2019
Cash
$31.22M
Q1 May 2019
Total Debt
$9.95M
Q1 May 2019
Shares Outstanding
10.76M sh
Q1 May 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.